Searches , social queries for MEPOLIZUMAB
Search references for MEPOLIZUMAB. Phrases containing MEPOLIZUMAB
See searches and references containing MEPOLIZUMAB!
Search references for MEPOLIZUMAB. Phrases containing MEPOLIZUMAB
See searches and references containing MEPOLIZUMAB!MEPOLIZUMAB
Monoclonal antibody medication
Mepolizumab, sold under the brand name Nucala, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis
Mepolizumab
Medical condition
with polyangiitis. Patients taking mepolizumab experienced a "significant improvement" in their symptoms. Mepolizumab is a monoclonal antibody that targets
Eosinophilic granulomatosis with polyangiitis
Eosinophilic_granulomatosis_with_polyangiitis
Unexplained chronic eosinophila
glucocorticoids such as prednisone. The addition of the monoclonal antibody mepolizumab may reduce the dose of glucocorticoids. Depending on eosinophil target-organ
Hypereosinophilic_syndrome
Type of white blood cells
eosinophils in blood are rapidly reduced monoclonal antibody therapy – e.g., mepolizumab or reslizumab against IL-5, prevents eosinophilopoiesis, or benralizumab
Eosinophil
Inflammation of the small intestine
diets to avoid food allergies, azathioprine and antibodies, including mepolizumab, omalizumab, infliximab, and adalimumab. The word enteritis (/ˌɛntəˈraɪtɪs/)
Enteritis
Medication
kappa). Depemokimab was developed by GSK. It is structurally similar to mepolizumab but contains seven amino acid substitutions in the heavy chain sequence
Depemokimab
Drug used to treat allergic diseases
since 2019 to develop a high-dose subcutaneous formulation of dupilumab. Mepolizumab, anti–IL-5 to treat chronic rhinosinusitis with nasal polyps Omalizumab
Dupilumab
Chronic inflammatory disease affecting the sinuses and lungs
market in recent years have been used to treat AERD including dupilumab, mepolizumab, omalizumab, and benralizumab. Among treatment options, biologics have
Aspirin-exacerbated respiratory disease
Aspirin-exacerbated_respiratory_disease
Medical condition
in order to alleviate symptoms. Some examples of these drugs include mepolizumab, reslizumab, and benralizumab. Although eosinopenia has long been recognized
Eosinopenia
Medical intervention
helminthic therapy; a drug to suppress toll-like receptor 9 (TLR9); and mepolizumab to treat eosinophilic esophagitis. Penicillin desensitization Castells
Desensitization_(medicine)
(naratriptan hydrochloride) Nimbex (cisatracurium besilate) Nucala (mepolizumab) Ojjaara (momelotinib) Otosporin ear drops (polymyxin B sulphate, neomycin
List_of_GSK_plc_products
Pattern of immune response
blockers: Altrakincept Pascolizumab IL-5-specific blockers: Benralizumab Mepolizumab Reslizumab IL-13-specific blockers: Lebrikizumab Tralokinumab Dual IL-4
Type_2_inflammation
Type of cytokine
there are two FDA-approved monoclonal antibodies that inhibit IL-5, mepolizumab and reslizumab. Additionally, the antibody benralizumab blocks the interleukin-5
Interleukin_5
Predisposition towards allergy
options with oral corticosteroids, biological treatments (e.g. omalizumab, mepolizumab) or allergen immunotherapy. Eczema Asthma Rhinitis Anaphylaxis Allergic
Atopy
Mammalian protein found in humans
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_2
Anti-inflammatory cytokine
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_10
Surgery to enlarge the paranasal sinus drainage pathways
biologic agents targeting the type 2 inflammatory pathway — dupilumab, mepolizumab, omalizumab, and related monoclonal antibodies — for the treatment of
Functional endoscopic sinus surgery
Functional_endoscopic_sinus_surgery
Drug used to treat asthma
Antibodies that aid in asthma symptomatic control include omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab and tezepelumab. Omalizumab binds
Anti-asthmatic_agent
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-12_subunit_beta
mepiroxol (INN) mepitiostane (INN) mepivacaine (INN) mepixanox (INN) mepolizumab (INN) mepramidil (INN) meprednisone (INN) Mepriam Mepro-Aspirin meprobamate
List_of_drugs:_Mep–Mes
Canadian health organization
2009, Firestone researchers demonstrated that an experimental drug, mepolizumab can help reduce eosinophil production in sufferers of severe asthma.
Firestone Institute for Respiratory Health
Firestone_Institute_for_Respiratory_Health
Monoclonal antibody
anti IL-4 antibody to treat chronic rhinosinusitis with nasal polyps mepolizumab, anti–IL-5 to treat chronic rhinosinusitis with nasal polyps omalizumab
Tezepelumab
Monoclonal antibody
Inebilizumab Itolizumab Lampalizumab† Letolizumab Ligelizumab† Lulizumab pegol Mepolizumab Mogamulizumab Natalizumab Ocrelizumab (+hyaluronidase) Omalizumab Ozoralizumab
Theralizumab
Biopharmaceutical drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Ustekinumab
Rare reaction to certain medications
T-cell activating cytokines including Il-5. The anti-IL-5 antibodies mepolizumab, reslizumab, and benralizumab have also been used to treat DRESS, and
Drug rash with eosinophilia and systemic symptoms
Drug_rash_with_eosinophilia_and_systemic_symptoms
Growth factor secreted by stromal cells in the bone marrow and thymus
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_7
Monoclonal antibody
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Guselkumab
Mammalian protein found in Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_1_beta
Monoclonal antibody against IL-17
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Secukinumab
Monoclonal antibody
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Pacibekitug
Medical condition
eosinophilic granulomatosis with polyangiitis can be successfully treated with mepolizumab. Idiopathic hypereosinophilic syndrome and lymphocyte-variant hypereosinophilia:
Eosinophilic_myocarditis
Mammalian cytokine
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_40
Monoclonal antibody
Inebilizumab Itolizumab Lampalizumab† Letolizumab Ligelizumab† Lulizumab pegol Mepolizumab Mogamulizumab Natalizumab Ocrelizumab (+hyaluronidase) Omalizumab Ozoralizumab
Spartalizumab
Pharmaceutical drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Anakinra
Marker on immune cells
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
CD4
Epidermal growth factor receptor (EGFR) colorectal, lung and stomach cancer Mepolizumab Nucala mab humanized IL-5 Y asthma and white blood cell diseases Metelimumab
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Chronic inflammatory and obstructive disease of the lungs
These monoclonal antibodies include omalizumab (an Anti-IgE antibody), mepolizumab (an anti-IL-5 antibody) and benralizumab (an anti-IL-5 receptor α antibody)
Asthma-COPD_overlap
Immunoglobulin superfamily
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-1_receptor_family
Medical condition
eosinophilic granulomatosis with polyangiitis can be successfully treated with mepolizumab. Idiopathic hypereosinphilic syndrome and lymphocyte-variant hypereosinophilia:
Loeffler_endocarditis
Monoclonal antibody
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Olokizumab
Mammalian protein found in Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_8_receptor,_beta
Type I cytokine receptor
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-12_receptor
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
IL31RA
Member of the interleukin 1 receptor family
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
ST2_cardiac_biomarker
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
IL36G
Monoclonal antibody
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Pascolizumab
Type of receptor
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-20_receptor
Immunosuppressive drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Tocilizumab
Interleukin
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_12
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin 27 receptor, alpha subunit
Interleukin_27_receptor,_alpha_subunit
Cell surface receptors specific for interleukin-5
antibodies are available to target IL-5R. Benralizumab binds to IL-5Ra, while mepolizumab and reslizumab bind to IL-5, preventing it from binding to IL-5Ra. Takatsu
Interleukin-5_receptor
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin 15 receptor, alpha subunit
Interleukin_15_receptor,_alpha_subunit
Pharmaceutical drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Canakinumab
Medical condition
substitutes include interferon-α or its analog, peginterferon alfa-2a, mepolizumab (an antibody directed against IL-5), ciclosporin (an immunosuppressive
Lymphocyte-variant hypereosinophilia
Lymphocyte-variant_hypereosinophilia
Overview of and topical guide to immunology
Secukinumab Siltuximab Sirukumab Spesolimab Tocilizumab Interleukin 5 Mepolizumab Immunoglobulin E Omalizumab Interferon Faralimomab IL-6 Elsilimomab IL-12
Outline_of_immunology
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin 11 receptor alpha subunit
Interleukin_11_receptor_alpha_subunit
7-transmembrane protein
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-8_receptor
Protein-coding gene in the species Homo sapiens
Protein unc-119 homolog, and SDCBP Cluster of differentiation Benralizumab Mepolizumab Reslizumab GRCh38: Ensembl release 89: ENSG00000091181 – Ensembl, May
Interleukin 5 receptor alpha subunit
Interleukin_5_receptor_alpha_subunit
Protein, encoded in humans by IL22 gene
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_22
Cytokine protein
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_6
Group of cytokine proteins
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-1_family
Lymphocyte receptor specific for Interleukin-2
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
IL-2_receptor
Protein complex
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-15_receptor
Pharmaceutical drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Basiliximab
Mammalian protein found in humans
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_8
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_1-alpha
Transmembrane protein found in humans
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-22_receptor
Monoclonal antibody
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Lebrikizumab
Drugs to suppress IL-6 signalling
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Anti-interleukin-6
Medical condition
treatments used in eosinophil-related disorders have been tried, but mepolizumab (which blocks the interleukin 5 receptor) was not as effective as had
Gleich's_syndrome
Cytokine that belongs to the IL-17 cytokine family
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_25
Protein found in humans
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-6_receptor
Protein and coding gene in humans
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_13
Mammalian protein found in Mus musculus
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_4
Protein found in humans
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_20
Heterodimeric cytokine acting as mediator of inflammation
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_23
Monoclonal antibody
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Inolimomab
Protein-coding gene in humans
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Common_gamma_chain
Form of immunotherapy
human Tissue factor pathway inhibitor hemophilia A and B 761369 Link mepolizumab Nucala GlaxoSmithKline 11/4/2015 subcutaneous humanized IL-5 severe asthma
Monoclonal_antibody_therapy
Mammalian protein found in Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
IL2RA
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-17A
Monoclonal antibody drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Tucotuzumab_celmoleukin
Group of cytokines
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin
Cytokine with structural similarity to Interleukin-2
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_15
Medication used to treat autoimmune diseases
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Ixekizumab
Cell surface receptor for interleukin-10
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-10_receptor
Protein found in humans
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interferon_lambda_receptor_1
Group of blood-based disorders
Bagnasco D, Ferrando M, Puggioni F, Passalacqua G, Canonica GW (2017). "Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence
Clonal_hypereosinophilia
Protein-coding gene in the species Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
IL1RAP
Pharmaceutical drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Daclizumab
Mammalian protein found in Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-3_receptor
Pharmaceutical drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Denileukin_diftitox
Type I cytokine receptor
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin-11_receptor
Pharmaceutical drug classification
Omalizumab R03DX06 Seratrodast R03DX07 Roflumilast R03DX08 Reslizumab R03DX09 Mepolizumab R03DX10 Benralizumab R03DX11 Tezepelumab R03DX12 Depemokimab "ATC (Anatomical
ATC_code_R03
Group of proteins
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_17
Protein that in humans is encoded by the IL33 gene
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interleukin_33
Group of anti-viral cytokines
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Interferon_type_III
Mammalian protein found in Homo sapiens
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Glycoprotein_130
Pharmaceutical drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Oprelvekin
Pharmaceutical drug
Agonists: Interleukin 5 Antagonists: YM-90709 Antibodies: Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists: Atexakin
Reslizumab
travel, tourism, insurance
MEPOLIZUMAB
MEPOLIZUMAB
MEPOLIZUMAB
MEPOLIZUMAB
MEPOLIZUMAB
MEPOLIZUMAB
MEPOLIZUMAB
MEPOLIZUMAB
MEPOLIZUMAB
travel, tourism, insurance